Van Lint 1997.
| Methods | Randomized controlled trial | |
| Participants | Acute GvHD after allogenic BMT, not responding to 48 hours of 0.5 mg/kg of 6‐MP | |
| Interventions | High dose (10mg/kg) 6‐MP vs low dose (2mg/kg) 6‐MP, both reduced every 5 days | |
| Outcomes | Clinical response Evolution to aGvHD III‐IV CMV infection actuarial TRM Relapse | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment? | Unclear risk | B ‐ Unclear |